AAAAAA
Results:
1-19
|
Results: 19
Authors:
Curran, D
Luo, ZY
Citation: D. Curran et Zy. Luo, Fluorous techniques for the synthesis and separation of organic molecules (vol 3, pg G3, 2001), GREEN CHEM, 3(3), 2001, pp. G39-G39
Authors:
Curran, D
Lee, ZY
Citation: D. Curran et Zy. Lee, Fluorous techniques for the synthesis and separation of organic molecules, GREEN CHEM, 3(1), 2001, pp. G3-G7
Authors:
Wagenaar, HC
Pecorelli, S
Vergote, I
Curran, D
Wagener, DJT
Kobierska, A
Bolis, G
ten Bokkel-Huinink, W
Lacave, AJ
Madronal, C
Forni, M
de Oliveira, CF
Mangioni, C
Nooij, MA
Goupil, A
Kerbrat, P
Marth, C
Tumolo, S
Herben, MG
Zanaboni, F
Vermorken, JB
Citation: Hc. Wagenaar et al., Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced Fallopian tube carcinoma - An EORTC Gynecological Cancer Group Study, EUR J GYN O, 22(3), 2001, pp. 187-193
Authors:
de Haes, J
Curran, D
Young, T
Bottomley, A
Flechtner, H
Aaronson, N
Blazeby, J
Bjordal, K
Brandberg, Y
Greimel, E
Maher, J
Sprangers, M
Cull, A
Citation: J. De Haes et al., Quality of life evaluation in oncological clinical trials - the EORTC model, EUR J CANC, 36(7), 2000, pp. 821-825
Authors:
Curran, D
Aaronson, N
Standaert, B
Molenberghs, G
Therasse, P
Ramirez, A
Koopmanschap, M
Erder, H
Piccart, M
Citation: D. Curran et al., Summary measures and statistics in the analysis of quality of life data: an example from an EORTC-NCIC-SAKK locally advanced breast cancer study, EUR J CANC, 36(7), 2000, pp. 834-844
Authors:
Bjordal, K
de Graeff, A
Fayers, PM
Hammerlid, E
van Pottelsberghe, C
Curran, D
Ahlner-Elmqvist, M
Maher, EJ
Meyza, JW
Bredart, A
Soderholm, AL
Arraras, JJ
Feine, JS
Abendstein, H
Morton, RP
Pignon, T
Huguenin, P
Bottomly, A
Kaasa, S
Citation: K. Bjordal et al., A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients, EUR J CANC, 36(14), 2000, pp. 1796-1807
Authors:
Kramer, JA
Curran, D
Piccart, M
de Haes, JCJM
Bruning, PF
Klijn, JGM
Bontenbal, M
van Pottelsberghe, C
Groenvold, M
Paridaens, R
Citation: Ja. Kramer et al., Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist, EUR J CANC, 36(12), 2000, pp. 1488-1497
Authors:
Kramer, JA
Curran, D
Piccart, M
de Haes, JCJM
Bruning, P
Klijn, J
Van Hoorebeeck, I
Paridaens, R
Citation: Ja. Kramer et al., Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer, EUR J CANC, 36(12), 2000, pp. 1498-1506
Authors:
Piccart, MJ
Green, JA
Lacave, AJ
Reed, N
Vergote, I
Benedetti-Panici, P
Bonetti, A
Kristeller-Tome, V
Fernandez, CM
Curran, D
Van Glabbeke, M
Lacombe, D
Pinel, MC
Pecorelli, S
Citation: Mj. Piccart et al., Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A randomized phase II study of the European Organization for Research and Treatment of Cancer Gynecology Group, J CL ONCOL, 18(6), 2000, pp. 1193-1202
Authors:
Postmus, PE
Haaxma-Reiche, H
Smit, EF
Groen, HJM
Karnicka, H
Lewinski, T
van Meerbeeck, J
Clerico, M
Gregor, A
Curran, D
Sahmoud, T
Kirkpatrick, A
Giaccone, G
Citation: Pe. Postmus et al., Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of theEuropean Organization for the Research and Treatment of Cancer Lung CancerCooperative Group, J CL ONCOL, 18(19), 2000, pp. 3400-3408
Authors:
Van Zandwijk, N
Smit, EF
Kramer, GWP
Schramel, F
Gans, S
Festen, J
Termeer, A
Schlosser, NJJ
Debruyne, C
Curran, D
Giaccone, G
Citation: N. Van Zandwijk et al., Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955), J CL ONCOL, 18(14), 2000, pp. 2658-2664
Authors:
Fossa, SD
Curran, D
Aaronson, NK
Keuppens, F
Kliment, J
Robinson, MRG
DeReijke, TM
Hetherington, J
Kil, PJM
Rea, LA
Citation: Sd. Fossa et al., Quality of life of patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C - Results from the EORTC phase-III Trial 30893, EUR UROL, 37(5), 2000, pp. 541-551
Authors:
Wilson, KG
Scott, JF
Graham, ID
Kozak, JF
Chater, S
Viola, RA
de Faye, BJ
Weaver, LA
Curran, D
Citation: Kg. Wilson et al., Attitudes of terminally ill patients toward euthanasia and physician-assisted suicide, ARCH IN MED, 160(16), 2000, pp. 2454-2460
Authors:
Pecorelli, S
Wagenaar, HC
Vergote, IB
Curran, D
Beex, LVA
Wiltshaw, E
Vermorken, JB
Citation: S. Pecorelli et al., Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC gynaecological cancer cooperative group study, EUR J CANC, 35(9), 1999, pp. 1331-1337
Authors:
Curran, D
Sylvester, RJ
Boes, GH
Citation: D. Curran et al., Sample size estimation in phase III cancer clinical trials, EUR J SUR O, 25(3), 1999, pp. 244-250
Authors:
Rosendahl, I
Kiebert, GM
Curran, D
Cole, BF
Weeks, JC
Denis, LJ
Hall, RR
Citation: I. Rosendahl et al., Quality-adjusted survival (Q-TWiST) analysis of EORTC trial 30853: Comparing goserelin acetate and flutamide with bilateral orchiectomy in patients with metastatic prostate cancer, PROSTATE, 38(2), 1999, pp. 100-109
Authors:
Ehrlich, R
Curran, D
Citation: R. Ehrlich et D. Curran, Major HDD TMR sources and projected scaling with TPI, IEEE MAGNET, 35(2), 1999, pp. 885-891
Authors:
Curran, D
Citation: D. Curran, Nyau masks and ritual (The spiritual practice of the Chewa people of Central Malawi), AFR ART, 32(3), 1999, pp. 68-77
Authors:
Kiebert, GM
Curran, D
Aaronson, NK
Bolla, M
Menten, J
Rutten, EHJM
Nordman, E
Silvestre, ME
Pierart, M
Karim, ABMF
Citation: Gm. Kiebert et al., Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: Results of a randomised phase III trial on dose response (EORTC trial 22844), EUR J CANC, 34(12), 1998, pp. 1902-1909
Risultati:
1-19
|